Opiant Pharmaceuticals OPNT

Quarterly report 2022-Q3
added 11-14-2022

Opiant Pharmaceuticals DIO Ratio 2011-2026 | OPNT

Annual DIO Ratio Opiant Pharmaceuticals

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	16.1	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
16.1	16.1	16.1

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	ACADIA Pharmaceuticals ACAD	295	$ 22.79	1.95 %	$ 3.78 B	USA
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Albireo Pharma ALBO	26.1	-	-0.23 %	$ 916 M	USA
	Arcutis Biotherapeutics ARQT	185	$ 23.55	0.56 %	$ 3 B	USA
	Autolus Therapeutics plc AUTL	70.7	$ 1.69	2.74 %	$ 450 M	Britain
	Завод ДИОД DIOD	768	-	-	-	Russia
	Фармсинтез LIFE	120	-	-	-	Russia
	AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain
	BioDelivery Sciences International BDSI	321	-	-4.8 %	$ 255 M	USA
	BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands